Package 71309-461-56

{"route": ["ORAL"], "spl_id": "f7f18eb7-a4bc-b7f6-e053-6394a90a0f74", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0371309461565"], "unii": ["495W7451VQ"], "rxcui": ["310621"], "spl_set_id": ["e2a3d6cb-5251-b88e-e053-2a95a90a9e30"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Safrel Pharmaceuticals, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71309-461-56)", "package_ndc": "71309-461-56", "marketing_start_date": "20220629"}], "brand_name": "GUAIFENESIN", "product_id": "71309-461_f7f18eb7-a4bc-b7f6-e053-6394a90a0f74", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "71309-461", "generic_name": "GUAIFENESIN", "labeler_name": "Safrel Pharmaceuticals, LLC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "GUAIFENESIN", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA213420", "marketing_category": "ANDA", "marketing_start_date": "20201218", "listing_expiration_date": "20261231"}